19 results on '"Boers, Maarten"'
Search Results
2. Viewpoint: Glucocorticoids in the treatment of rheumatoid arthritis: points to (re)consider
3. E087 Reduced joint synovitis assessment versus the global EULAR OMERACT synovitis score (GLOESS) to predict the response to secukinumab in patients with active psoriatic arthritis and inadequate response to conventional disease-modifying anti-rheumatic drugs: exploratory results from the ULTIMATE trial
4. Safety and efficacy associated with long-term low-dose glucocorticoids in rheumatoid arthritis: a systematic review and meta-analysis
5. Self-monitoring combined with patient-initiated care in RA patients with low disease activity: cost-effectiveness analysis of an RCT
6. A multidisciplinary lifestyle program for rheumatoid arthritis: the ‘Plants for Joints’ randomized controlled trial
7. Favourable effect of a ‘second hit’ after 13 weeks in early RA non-responders: the Amsterdam COBRA treat-to-target randomized trial
8. Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids
9. P253 Ultrasound demonstrates continued improvement in psoriatic arthritis synovitis and enthesitis with secukinumab: 52-week results from a Phase 3 study
10. Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATE
11. P187 Secukinumab significantly decreased joint synovitis measured by Power Doppler ultrasonography in biologic-naive patients with active psoriatic arthritis: primary (12week) results from a randomised, placebo-controlled Phase 3 study
12. 217 Results of a patient survey on feasibility and face validity of outcome measures for intended use in future studies enrolling participants with polymyalgia rheumatica
13. Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies
14. Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trial
15. HOW OUTCOME MEASURES IN RHEUMATOID ARTHRITIS CLINICAL TRIALS WORKS TO DEVELOP OUTCOME MEASURES IN RHEUMATOLOGY CLINICAL TRIALSI116. CHOOSING AND DEVELOPING CORE OUTCOME MEASUREMENT SETS FOR CLINICAL TRIALS: OUTCOME MEASURES IN RHEUMATOID ARTHRITIS CLINICAL TRIALS FILTER 2.0
16. Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project
17. Risk of serious adverse effects of biological and targeted drugs in patients with rheumatoid arthritis: a systematic review meta-analysis
18. The short-term effects of two high-dose, step-down prednisolone regimens on body composition in early rheumatoid arthritis
19. Validity and measurement precision of the PROMIS physical function item bank and a content validity–driven 20-item short form in rheumatoid arthritis compared with traditional measures
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.